There were several errors in the Summer 2005 issue. It was incorrectly stated that duloxetine (Cymbalta) is not approved for the treatment of diabetic neuropathy (page 51). In fact, the Food and Drug Administration approved the medication for this use in September 2004. In addition, Neurology Now apologizes for misspelling names. The corrections follow: Stanley Prusiner, M.D and Ronald C. Petersen, Ph.D., M.D. (page 54); Juliana Lee (64).